545.8500 -19.55 (-3.46%)
NSE Jan 19, 2026 09:07 AM
Volume: 91
 

545.85
-3.46%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters unpledged 3.63% of shares in last quarter. Total pledge stands at 35.32% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended